sb 206553 has been researched along with cgp 20712a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callebert, J; Etienne, N; Jaffré, F; Launay, JM; Maroteaux, L; Monassier, L; Nebigil, CG; Sarre, A | 1 |
1 other study(ies) available for sb 206553 and cgp 20712a
| Article | Year |
|---|---|
Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Cardiomegaly; Cells, Cultured; Drug Evaluation, Preclinical; Fibroblasts; Gene Expression Regulation; Heart Ventricles; Imidazoles; Indoles; Interleukin-1; Interleukin-6; Isoproterenol; Mice; Mice, Knockout; Myocytes, Cardiac; Propanolamines; Pyridines; Quinolines; Receptor, Serotonin, 5-HT2B; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sympathetic Nervous System; Sympathomimetics; Tumor Necrosis Factor-alpha | 2004 |